Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.bbalip.2013.10.003PMID 24120919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.

  2014cited by this paper
• LPA1‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation

  2013cited by this paper
• Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice

  2013cited by this paper
• Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves.

  2013cited by this paper
• Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance.

  2012cited by this paper
• Insights into the pharmacological relevance of lysophospholipid receptors

  2012cited by this paper
• Selective Inhibition of Hypoxia-Inducible Factor 1α Ameliorates Adipose Tissue Dysfunction

  2012cited by this paper
• The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.

  2012cited by this paper
• Adipose tissue remodeling in children: the link between collagen deposition and age-related adipocyte growth.

  2012cited by this paper
• Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes

  2012cited by this paper
• Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.

  2012cited by this paper
• PRR5L degradation promotes MTORC2-mediated PKCδ phosphorylation and cell migration downstream of Gα12

  2012cited by this paper
• TGFbeta Family Members Are Key Mediators in the Induction of Myofibroblast Phenotype of Human Adipose Tissue Progenitor Cells by Macrophages

  2012cited by this paper
• Apolipoprotein A-I Mimetic Peptides Inhibit Expression and Activity of Hypoxia-Inducible Factor-1α in Human Ovarian Cancer Cell Lines and a Mouse Ovarian Cancer Model

  2012cited by this paper
• Depot-specific regulation of autotaxin with obesity in human adipose tissue

  2012cited by this paper
• Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat

  2011cited by this paper
• Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

  2011cited by this paper
• Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling

  2011cited by this paper
• Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.

  2011cited by this paper
• The differential role of Hif1β/Arnt and the hypoxic response in adipose function, fibrosis, and inflammation.

  2011cited by this paper
• Autotaxin as a novel serum marker of liver fibrosis.

  2011cited by this paper
• Lysophosphatidic acid-1-receptor targeting agents for fibrosis

  2011cited by this paper
• Disruption of Hypoxia-Inducible Factor 1 in Adipocytes Improves Insulin Sensitivity and Decreases Adiposity in High-Fat Diet–Fed Mice

  2011cited by this paper
• Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist

  2011cited by this paper
• Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue

  2011cited by this paper
• Gα12 Activation in Podocytes Leads to Cumulative Changes in Glomerular Collagen Expression, Proteinuria and Glomerulosclerosis

  2011cited by this paper
• Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass Loss

  2010cited by this paper
• Adipocyte extracellular matrix composition, dynamics and role in obesity

  2010cited by this paper
• Lysophosphatidic Acid Receptors LPA1 and LPA3 Promote CXCL12-Mediated Smooth Muscle Progenitor Cell Recruitment in Neointima Formation

  2010cited by this paper
• A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model

  2010cited by this paper
• Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation.

  2010cited by this paper
• Effect of histidine on autotaxin activity in experimentally induced liver fibrosis

  2010cited by this paper
• Adipose tissue collagen VI in obesity.

  2009cited by this paper
• Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).

  2009cited by this paper
• Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes.

  2009cited by this paper
• Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue

  2009cited by this paper
• Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts.

  2009cited by this paper
• LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia‐inducible factor‐1α and the PI3K pathway

  2008cited by this paper
• The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak

  2008cited by this paper
• Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI

  2008cited by this paper
• LPA1 receptor activation promotes renal interstitial fibrosis.

  2007cited by this paper
• Both Plasma Lysophosphatidic Acid and Serum Autotaxin Levels are Increased in Chronic Hepatitis C

  2007cited by this paper
• Is Autotaxin (ENPP2) the Link between Hepatitis C and Hepatocellular Cancer?

  2007cited by this paper
• Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids

  2007cited by this paper
• Secretion and lysophospholipase D activity of autotaxin by adipocytes are controlled by N-glycosylation and signal peptidase.

  2007cited by this paper
• Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity.

  2007cited by this paper
• Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.

  2007cited by this paper
• Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

  2006cited by this paper
• Activation of Hypoxia-Inducible Factor-1α Is Necessary for Lysophosphatidic Acid–Induced Vascular Endothelial Growth Factor Expression

  2006cited by this paper
• The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

  2006cited by this paper
• Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells

  2005cited by this paper
• Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression

  2005cited by this paper
• Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor γ2*

  2005cited by this paper
• Improvement of Postnatal Neovascularization by Human Adipose Tissue–Derived Stem Cells

  2004cited by this paper
• Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.

  2004cited by this paper
• Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells.

  2003cited by this paper
• Autotaxin Is Released from Adipocytes, Catalyzes Lysophosphatidic Acid Synthesis, and Activates Preadipocyte Proliferation

  2003cited by this paper
• Culture of Human Adipose Tissue Explants Leads to Profound Alteration of Adipocyte Gene Expression

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

  2003cited by this paper
• Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis.

  2002cited by this paper
• Adipose Tissue Expression of Gelatinases in Mouse Models of Obesity

  2001cited by this paper
• A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification.

  2000cited by this paper
• Induction of Connective Tissue Growth Factor by Activation of Heptahelical Receptors

  2000cited by this paper
• Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

  1998cited by this paper
• Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture.

  1998cited by this paper
• YC-1, a novel activator of platelet guanylate cyclase.

  1994cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• [Studies on heterocyclic compounds. XXXIV. Synthesis of furo[3,2-c]pyrazole derivatives. (2). Electrophilic substitution of 1,3-diphenylfuro[3,2-c]pyrazole (author's transl)].

  1978cited by this paper

• Effect of cardiomyocyte-specific lipid phosphate phosphatase 3 overexpression on high-fat diet-induced cardiometabolic dysfunction in mice.

  2025cites this paper
• Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks

  2025cites this paper
• Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis

  2024cites this paper
• Adipose tissue fibrosis: the unwanted houseguest invited by obesity.

  2023cites this paper
• Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease

  2021influential citation
• Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases

  2020cites this paper
• Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions

  2020cites this paper
• Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

  2019cites this paper
• Adipose Tissue CTGF Expression is Associated with Adiposity and Insulin Resistance in Humans

  2019cites this paper
• Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation

  2019cites this paper
• Biomarkers of insulin resistance, oxidative stress, and nutrition and the brain

  2019cites this paper
• Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance

  2018cites this paper
• The role of LPA in kidney pathologies

  2017cites this paper
• Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors.

  2017cites this paper
• Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index

  2017cites this paper
• Validation of optimal reference genes for quantitative real time PCR in muscle and adipose tissue for obesity and diabetes research

  2017cites this paper
• Adipose tissue: between the extremes

  2017influential citation
• Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.

  2017cites this paper
• Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature.

  2016cites this paper
• Short-term and rapid effects of lysophosphatidic acid on human adipose cell lipolytic and glucose uptake activities

  2016cites this paper
• Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer’s Disease Outcomes

  2016cites this paper
• Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer.

  2015cites this paper
• Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity.

  2015cites this paper
• Adipose tissue fibrosis.

  2015cites this paper
• Analysis of Edg-Like LPA Receptor-Ligand Interactions.

  2015cites this paper
• Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions.

  2014cites this paper
• Regulation of silicosis formation by lysophosphatidic acid and its receptors

  2014cites this paper
• The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders

  year unknowncites this paper